**Specifications Table**TableSubject area*Biology*More specific subject area*Cellular transcriptomics*Type of data*Tables, figure*How data was acquired*Affymetrix 7G Microarray Scanner (Affymetrix, Santa Clara, CA)*Data format*Filtered, analyzed*Experimental factors*Time-course experiments of gene expression responses of confluent human ECV304 endothelial cells, stimulated with recombinant IL-1β (100 IU/ml), to treatment with Aminaphtone (6 μg/ml) vs. medium alone*Experimental features*Whole-genome gene expression analysis performed at 1, 3, and 6-h time points using GeneChip Gene 1.0 ST Arrays (Affymetrix, Santa Clara, CA)*Data source location*Milan, Italy*Data accessibility*Filtered, analyzed data are reported within this article. Raw and normalized data are available via NCBI׳s GEO accession number GEO: GSE83297 (*[*http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83297*](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83297){#ir0005}*).*

Value of the data {#s0005}
=================

•Previously unreported transcriptional effects of Aminaphtone, a drug currently used for the treatment of chronic venous insufficiency.•Illustrate gene expression changes induced by Aminaphtone in a human endothelial cell line subjected to inflammatory stimulus.•May facilitate further experiments to unveil the still unknown mechanism of action of this drug.•May serve as a benchmark for comparison with data obtained in primary cells for further insight.•May stimulate further research on the clinical use of this drug in other disease conditions, in which inflammation and endothelial dysfunction are key pathophysiological elements.

1. Data {#s0010}
=======

Transcriptional effects of Aminaphtone treatment on human ECV304 endothelial cells stimulated with IL-1β for 1, 3 and 6 h are shown in [Table 1](#t0005){ref-type="table"}. The complete raw and normalized data are deposited in NCBI׳s Gene Expression Omnibus [@bib2] and are accessible through GEO Series accession number GEO: GSE83297 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83297>). A hierarchically clustered heatmap of the differentially expressed genes ([Fig. 1](#f0005){ref-type="fig"}) visualizes the arrangement of treatment groups into clusters. [Table 2](#t0010){ref-type="table"} illustrates data on the functional enrichment analysis of modulated genes, showing gene sets and molecular pathways affected by Aminaphtone in IL-1β stimulated ECV304 cells.

2. Experimental design, materials and methods {#s0015}
=============================================

2.1. Cell cultures and treatments {#s0020}
---------------------------------

Human ECV304 endothelial cells (European Collection of Authenticated Cell Cultures, ECACC No. 92091712) were seeded at ×10^5^/well in 6-well tissue-culture treated plates and grown to confluence in M199 complete medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT), at 37 °C in a humidified incubator with 5% CO~2~. Cells were serum starved (1% FBS) to synchronize the mitotic phase 24 h before treatment. Cells were then incubated for 1, 3, and 6 h with recombinant IL-1β 100 IU/ml (Sigma-Aldrich, St. Louis, MO) in the presence of Aminaphtone 6 μg/ml (Baldacci, Pisa, Italy) or an equal volume of medium alone. Experiments were performed in three independent replicates for each time point.

2.2. RNA isolation and whole-genome gene expression profiling {#s0025}
-------------------------------------------------------------

Total RNA extraction was performed with TRIzol (Life Technologies, Rockville, MD) directly added to the ECV304 culture plates. Removal of contaminating genomic DNA was done by treating RNA samples with RNase-free Turbo DNase (Life Technologies) for 15 min at room temperature. RNA quantity and quality were assessed respectively by micro-volume spectrophotometry on an Infinite 200 PRO plate reader (Tecan, Männedorf, Switzerland) and by on-chip capillary electrophoresis on a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Absorbance ratio at 260 and 280 nm was ≥1.9 and the RNA integrity number (RIN) was \>8 for all samples.

For each replicate, 100 ng of total RNA were amplified and labeled using the Whole-Transcript Sense Target Labeling Protocol by Affymetrix (Santa Clara, CA) without ribosomal RNA reduction. Affymetrix GeneChip Human Gene 1.0 ST arrays were hybridized with 11 µg of labeled sense DNA, washed, stained, and scanned on an Affymetrix 7G Scanner according to the manufacturer׳s protocols.

2.3. Data processing and probe mapping {#s0030}
--------------------------------------

Data were extracted using the Affymetrix Expression Console software. Background correction, log~2~ transformation, quantile normalization, and median polish probeset summarization was performed using the Robust Multi-array Average (RMA) method [@bib3] implemented in the RMAExpress software v1.0.5. The resulting dataset consisted of 28869 probesets. The BRB-ArrayTools v4.3.2 (developed by Dr. Richard Simon and BRB-ArrayTools Development Team) and Bioconductor *R* packages v2.12 [@bib4] were used for probe filtering and annotation. Probesets were deemed as non-informative and excluded from further analysis under any of the following conditions: *P*-value of the log-ratio variation greater than 0.01, *i.e.* genes showing minimal variation across samples; 17th percentile of intensity less than 10, *i.e.* genes with the lowest acceptable expression level at most in three samples. Multiple probesets were reduced to one per gene symbol by using the most variable probe measured by interquartile range across arrays. After applying these stringent quality control and gene filtering criteria, we analyzed the expression changes over time of 6461 genes. Project was annotated with the Bioconductor annotation package hugene10sttranscriptcluster.db v8.0.1.

2.4. Statistical and bioinformatics analysis {#s0035}
--------------------------------------------

Differentially expressed genes were sought combining two statistics implemented in the software MultiExperiment Viewer (MeV) v4.9 [@bib5]. To identify genes varying significantly between the two conditions across time points, we used the Bayesian Estimation of Temporal Regulation (BETR) method [@bib6], which is a linear random-effect modeling framework that takes into account correlations within samples between sampling times. Genes assigned a False Discovery Rate (FDR) \<0.1 were deemed significantly modulated. Then, to determine which genes were mainly influenced by the effect of Aminaphtone treatment *per se* (*i.e.* irrespective of the time response) and/or by the interaction effect of the two factors time and treatment, we applied a two-factor ANOVA to the gene list identified by BETR, given the balanced factorial design of the study. Genes were considered statistically significant if the *P*-values either for treatment and/or for interaction were \<0.05. We finally performed post-hoc pairwise comparisons (2-tailed Student׳s *t*-test) to identify significant differences (*P*\<0.05) between treatment classes at any time points.

Unsupervised hierarchical clustering was performed using the algorithms implemented in BRB-ArrayTools, to visualize similarities and differences in gene expression profiles that could discriminate treatment classes and/or changes over time. Log~2~ transformed, normalized gene expression values were median-centered, scaled, and clustered by Pearson׳s centered correlation and average linkage as distance metrics.

Functional analysis of significant genes identified by BETR was carried out by examining gene sets for differential expression between Aminaphtone treated and untreated samples. Gene sets were derived from the Gene Ontology (GO) database (<http://www.geneontology.org>) [@bib7], the Kyoto Encyclopedia of Genes and Genomes (KEGG; <http://www.genome.jp/kegg/pathway.html>), and the curated gene sets of the Broad Institute Molecular Signature Database (MSigDB) [@bib8]. LS/KS permutation tests were used to find gene sets with more genes differentially expressed among the phenotype classes than expected by chance. The threshold *P*-value was set at 0.005. Redundant GO terms were filtered out using the web-based tool REViGO [@bib9], allowing a similarity threshold of 0.5.
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![Unsupervised hierarchical clustering of significant genes modulated over time by Aminaphtone in treated *vs.* untreated IL-1β stimulated ECV304 endothelial cells. The BETR algorithm identified 252 significantly modulated genes (FDR \<0.1). Samples and genes were clustered using Pearson׳s correlation (centered) and average linkage method. Each combination of treatments and time points regrouped in distinct clusters. The log~2~ transformed, normalized, median-centered expression level of each gene is represented with a blue, black, and orange color scale: blue indicates below median, black, equal to, and orange above median. Class legends stand for: IL-1β (IL-1β without Aminaphtone); AMNA (IL-1β with Aminaphtone).](gr1){#f0005}

###### 

Differentially expressed genes in Aminaphtone-treated *vs.* untreated IL-1β-stimulated ECV304 endothelial cells.

Table 1

  **Symbol**           **Gene name**                                                                                                      **Gene ID**   **FDR**    ***P***~***treatment***~   ***P***~***interaction***~   **FC AMNA/IL-1β**   ***Pairwise***                                                                                                         
  -------------------- ------------------------------------------------------------------------------------------------------------------ ------------- ---------- -------------------------- ---------------------------- ------------------- ---------------- ------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
  ***AAK1***           AP2 associated kinase 1                                                                                            22848         9.13e-02   **5.98e-03**               7.26e-01                     1.55                1.66             1.31                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***ACAP1***          ArfGAP with coiled-coil, ankyrin repeat and PH domains 1                                                           9744          1.65e-02   **2.07e-04**               4.01e-01                     −1.50               −1.23            −1.36   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***AGAP2***          ArfGAP with GTPase domain, ankyrin repeat and PH domain 2                                                          116986        1.73e-03   **8.86e-05**               4.53e-01                     −1.39               −1.58            −1.31   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***AK4***            adenylate kinase 4                                                                                                 205           8.79e-03   4.27e-01                   **7.56e-04**                 1.41                −1.01            −1.64   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ANKRD1***         ankyrin repeat domain 1 (cardiac muscle)                                                                           27063         8.02e-03   **2.75e-02**               **1.23e-02**                 1.26                −1.46            −1.78                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ANKRD13A***       ankyrin repeat domain 13A                                                                                          88455         8.98e-02   **2.37e-04**               1.88e-01                     1.23                1.47             1.18    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***ANXA3***          annexin A3                                                                                                         306           4.39e-04   7.76e-02                   **7.05e-04**                 1.48                −1.33            −1.70   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***AREG***           amphiregulin                                                                                                       374           7.88e-02   **6.01e-03**               6.32e-01                     −1.37               −1.39            −1.78                                                                                                 [\*](#tbl1fnStar){ref-type="table-fn"}
  ***ARHGEF26***       Rho guanine nucleotide exchange factor (GEF) 26                                                                    26084         7.10e-02   **1.36e-03**               9.35e-01                     1.42                1.33             1.42    [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*](#tbl1fnStar){ref-type="table-fn"}
  ***ARL4C***          ADP-ribosylation factor-like 4C                                                                                    10123         2.31e-02   **2.22e-04**               8.41e-01                     −1.41               −1.30            −1.39   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ATF7IP2***        activating transcription factor 7 interacting protein 2                                                            80063         5.87e-02   **5.59e-03**               1.69e-01                     1.77                1.17             1.22    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***BCL2L11***        BCL2-like 11 (apoptosis facilitator)                                                                               10018         8.59e-04   **7.06e-05**               **3.23e-02**                 1.60                1.48             1.09    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***BCL3***           B-cell CLL/lymphoma 3                                                                                              602           4.12e-03   **3.18e-02**               **5.00e-03**                 −1.98               −1.05            1.13    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***BMP6***           bone morphogenetic protein 6                                                                                       654           1.78e-02   **3.25e-03**               6.12e-02                     −1.00               1.65             1.47                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***BNIP3***          BCL2/adenovirus E1B 19 kDa interacting protein 3                                                                   664           0.00e+00   **3.64e-05**               **4.09e-06**                 1.11                −1.12            −2.54                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***BRCA1***          breast cancer 1, early onset                                                                                       672           7.46e-02   4.42e-01                   **1.64e-02**                 1.96                −1.28            −1.15   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***BUB1***           BUB1 mitotic checkpoint serine/threonine kinase                                                                    699           1.40e-02   5.76e-01                   **5.38e-03**                 1.93                −1.28            −1.26   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***BUB1B***          BUB1 mitotic checkpoint serine/threonine kinase B                                                                  701           5.11e-02   4.12e-01                   **1.69e-02**                 2.09                −1.32            −1.14   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***C14orf105***      chromosome 14 open reading frame 105                                                                               55195         6.13e-02   **4.75e-03**               5.28e-01                     −1.22               −1.59            −1.62                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***C15orf48***       chromosome 15 open reading frame 48                                                                                84419         5.83e-03   **7.16e-05**               **4.51e-02**                 −1.61               −1.17            −1.25   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***C1orf63***        chromosome 1 open reading frame 63                                                                                 57035         3.07e-03   **1.82e-04**               3.43e-01                     1.61                1.27             1.38    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***C2orf44***        chromosome 2 open reading frame 44                                                                                 80304         9.87e-03   **1.63e-03**               2.02e-01                     1.79                1.35             1.20    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***C3orf58***        chromosome 3 open reading frame 58                                                                                 205428        1.08e-05   3.22e-01                   **1.35e-06**                 1.54                1.17             −1.61   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***C7orf53***        chromosome 7 open reading frame 53                                                                                 286006        6.37e-05   **1.06e-03**               **1.05e-02**                 2.19                1.05             1.27    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***C9orf131***       chromosome 9 open reading frame 131                                                                                138724        9.82e-03   **4.39e-04**               7.67e-02                     1.67                1.21             1.19    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CACHD1***         cache domain containing 1                                                                                          57685         4.66e-02   **2.02e-03**               4.84e-01                     1.31                1.63             1.29                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***CBLB***           Cbl proto-oncogene, E3 ubiquitin protein ligase B                                                                  868           8.71e-02   **1.29e-02**               2.19e-01                     1.07                1.86             1.45                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***CCL22***          chemokine (C--C motif) ligand 22                                                                                   6367          0.00e+00   **6.98e-06**               6.53e-02                     −1.36               −2.20            −1.99   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***CD70***           CD70 molecule                                                                                                      970           9.39e-02   **1.09e-03**               2.37e-01                     −1.53               −1.22            −1.20   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CD83***           CD83 molecule                                                                                                      9308          1.63e-03   **4.10e-04**               8.35e-02                     1.80                1.22             1.27    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CEBPD***          CCAAT/enhancer binding protein (C/EBP), delta                                                                      1052          6.06e-03   4.58e-01                   **6.34e-04**                 −1.70               1.12             1.31    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***CENPF***          centromere protein F, 350/400 kDa                                                                                  1063          8.68e-02   6.92e-01                   **2.45e-02**                 1.90                −1.75            −1.31   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***CEP55***          centrosomal protein 55 kDa                                                                                         55165         4.42e-02   7.14e-01                   **8.10e-03**                 1.68                −1.40            −1.35   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***CEP76***          centrosomal protein 76 kDa                                                                                         79959         7.67e-02   **2.29e-03**               1.52e-01                     1.57                1.32             1.09    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***CHCHD7***         coiled-coil-helix-coiled-coil-helix domain containing 7                                                            79145         6.62e-02   **3.19e-03**               4.05e-01                     1.58                1.47             1.17    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***CITED2***         Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2                                  10370         7.93e-02   2.38e-01                   **3.69e-03**                 −1.38               1.47             1.22    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***CKAP2L***         cytoskeleton associated protein 2-like                                                                             150468        1.53e-02   1.45e-01                   **1.89e-02**                 1.57                −1.97            −1.57                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***CLEC4E***         C-type lectin domain family 4, member E                                                                            26253         4.03e-03   **8.42e-04**               3.66e-01                     −1.25               −1.53            −1.71                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***CNNM4***          cyclin M4                                                                                                          26504         1.79e-07   **9.46e-05**               **4.77e-04**                 −1.11               2.00             1.57                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***CSF2***           colony stimulating factor 2 (granulocyte-macrophage)                                                               1437          1.02e-03   **8.79e-04**               7.21e-01                     −1.68               −1.88            −1.48   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***CTH***            cystathionase (cystathionine gamma-lyase)                                                                          1491          6.66e-03   **1.90e-04**               3.46e-01                     1.29                1.59             1.31    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***CTSK***           cathepsin K                                                                                                        1513          2.91e-03   **4.28e-04**               9.47e-01                     1.54                1.53             1.45    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***CUZD1***          CUB and zona pellucida-like domains 1                                                                              50624         7.05e-02   **3.72e-02**               **4.52e-02**                 1.95                1.02             1.05    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CX3CL1***         chemokine (C-X3-C motif) ligand 1                                                                                  6376          1.25e-02   **3.11e-03**               4.58e-01                     −1.94               −1.48            −1.33   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CXCL3***          chemokine (C-X-C motif) ligand 3                                                                                   2921          8.34e-02   **1.65e-02**               5.71e-02                     −1.70               −1.34            1.07    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***CXCL6***          chemokine (C-X-C motif) ligand 6                                                                                   6372          2.85e-03   **1.69e-04**               6.11e-01                     −1.39               −1.34            −1.58   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***CYB5D1***         cytochrome b5 domain containing 1                                                                                  124637        2.40e-03   **1.21e-03**               7.39e-02                     1.78                1.50             1.07    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***CYP24A1***        cytochrome P450, family 24, subfamily A, polypeptide 1                                                             1591          2.62e-05   **4.54e-05**               7.89e-01                     −1.52               −1.69            −1.51   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***DBR1***           debranching enzyme homolog 1 (*Saccharomyces cerevisiae*)                                                          51163         7.97e-02   **1.06e-03**               4.21e-01                     1.52                1.26             1.24    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***DDIT4***          DNA-damage-inducible transcript 4                                                                                  54541         5.57e-04   **5.87e-04**               5.05e-01                     −1.90               −1.40            −1.57   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***DDR1***           discoidin domain receptor tyrosine kinase 1                                                                        780           1.43e-02   **1.48e-03**               8.30e-02                     −1.73               −1.26            −1.13   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***DENND2C***        DENN/MADD domain containing 2C                                                                                     163259        3.14e-02   **1.33e-03**               9.57e-01                     1.44                1.49             1.40    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***DEPDC1***         DEP domain containing 1                                                                                            55635         5.44e-02   9.05e-01                   **1.02e-02**                 1.75                −1.26            −1.44   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***DKK1***           dickkopf 1 homolog (*Xenopus laevis*)                                                                              22943         2.94e-05   **5.83e-05**               **1.71e-02**                 −1.25               −1.25            −1.94                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***DLEU1***          deleted in lymphocytic leukemia 1 (non-protein coding)                                                             10301         7.23e-02   **5.02e-03**               1.27e-01                     1.71                1.19             1.14    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***DLGAP5***         discs, large (Drosophila) homolog-associated protein 5                                                             9787          4.29e-03   1.58e-01                   **2.80e-03**                 1.51                −1.58            −1.42   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***DNAJB1***         DnaJ (Hsp40) homolog, subfamily B, member 1                                                                        3337          1.36e-02   **4.99e-03**               **4.35e-02**                 1.82                1.31             1.00    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***DUSP8***          dual specificity phosphatase 8                                                                                     1850          5.16e-03   **1.05e-02**               **4.26e-03**                 −1.87               1.06             −1.07   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***EBI3***           Epstein-Barr virus induced 3                                                                                       10148         0.00e+00   **6.30e-06**               6.87e-01                     −1.82               −1.73            −2.06   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ECT2***           epithelial cell transforming sequence 2 oncogene                                                                   1894          6.84e-03   5.43e-02                   **1.07e-02**                 1.36                −1.84            −1.45                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***EDN1***           endothelin 1                                                                                                       1906          0.00e+00   **2.33e-06**               8.60e-01                     −1.79               −1.93            −1.97   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***EFNA1***          ephrin-A1                                                                                                          1942          4.91e-03   **1.20e-03**               **2.03e-02**                 −1.74               −1.02            −1.31   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***EFNB2***          ephrin-B2                                                                                                          1948          1.76e-02   **3.27e-03**               1.81e-01                     1.81                1.40             1.13    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***EGR2***           early growth response 2                                                                                            1959          7.52e-03   **3.57e-03**               **6.43e-03**                 −1.80               −1.04            −1.06   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***EIF4B***          eukaryotic translation initiation factor 4B                                                                        1975          3.63e-02   4.03e-01                   **9.48e-03**                 1.56                −1.22            −1.69   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*](#tbl1fnStar){ref-type="table-fn"}
  ***EIF4EBP2***       eukaryotic translation initiation factor 4E binding protein 2                                                      1979          3.09e-04   **5.53e-06**               1.55e-01                     1.25                1.56             1.42    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ELF3***           E74-like factor 3 (ets domain transcription factor, epithelial-specific )                                          1999          6.05e-02   **3.62e-02**               **8.45e-03**                 −1.24               1.43             1.43                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***ELMSAN1***        ELM2 and Myb/SANT-like domain containing 1                                                                         91748         3.96e-05   **1.34e-02**               **1.00e-05**                 −1.86               1.19             1.08    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***ELOVL4***         ELOVL fatty acid elongase 4                                                                                        6785          8.64e-03   **5.29e-04**               3.98e-01                     1.40                1.62             1.25    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***ELOVL6***         ELOVL fatty acid elongase 6                                                                                        79071         7.35e-02   1.86e-01                   **1.29e-02**                 1.84                −1.08            −1.15   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ENO2***           enolase 2 (gamma, neuronal)                                                                                        2026          6.53e-05   **1.50e-03**               **1.22e-02**                 −1.27               −1.06            −2.31                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ERCC6L***         excision repair cross-complementing rodent repair deficiency, complementation group 6-like                         54821         6.72e-02   8.17e-01                   **1.39e-02**                 1.75                −1.58            −1.21   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***ERF***            Ets2 repressor factor                                                                                              2077          1.91e-02   **4.84e-04**               1.05e-01                     −1.62               −1.22            −1.19   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***EVA1A***          eva-1 homolog A (*Caenorhabditis elegans*)                                                                         84141         1.25e-06   **3.14e-07**               **4.49e-03**                 −1.19               −1.47            −1.74   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***FAM102A***        family with sequence similarity 102, member A                                                                      399665        3.29e-02   6.69e-02                   **5.48e-03**                 −1.32               1.41             1.48                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***FAM111B***        family with sequence similarity 111, member B                                                                      374393        7.05e-02   5.89e-01                   **2.31e-02**                 2.18                −1.58            −1.06   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***FAM46C***         family with sequence similarity 46, member C                                                                       54855         5.99e-04   **5.82e-04**               **4.90e-03**                 1.87                1.20             1.03    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***FAM72D***         family with sequence similarity 72, member D                                                                       728833        2.54e-04   4.65e-01                   **1.25e-03**                 1.86                −1.60            −1.46   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***FBLIM1***         filamin binding LIM protein 1                                                                                      54751         1.21e-03   **1.31e-04**               5.98e-01                     −1.61               −1.38            −1.39   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***FBXL20***         F-box and leucine-rich repeat protein 20                                                                           84961         1.87e-04   **2.46e-04**               6.47e-02                     1.19                1.91             1.40                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***FBXO33***         F-box protein 33                                                                                                   254170        4.21e-02   **9.72e-04**               7.70e-02                     1.22                1.62             1.13                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***FLJ36840***       uncharacterized LOC645524                                                                                          645524        2.12e-02   1.52e-01                   **2.64e-02**                 2.66                −1.34            1.09    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***FOS***            FBJ murine osteosarcoma viral oncogene homolog                                                                     2353          4.65e-06   **4.26e-04**               **3.84e-04**                 2.13                1.01             1.08    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***FRMD6***          FERM domain containing 6                                                                                           122786        4.02e-02   **1.16e-02**               **3.29e-02**                 1.11                −1.49            −1.57                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***FRMD8***          FERM domain containing 8                                                                                           83786         3.02e-02   **6.15e-03**               **2.25e-02**                 −1.72               −1.23            1.03    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***FST***            follistatin                                                                                                        10468         7.49e-02   **1.12e-03**               1.27e-01                     −1.07               −1.44            −1.42                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***FUT11***          fucosyltransferase 11 (alpha (1,3) fucosyltransferase)                                                             170384        5.23e-02   **1.79e-03**               **6.02e-03**                 −1.14               1.00             −1.62                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***GAN***            gigaxonin                                                                                                          8139          4.82e-02   **6.57e-03**               1.16e-01                     1.80                1.22             1.12    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GAREM***          GRB2 associated, regulator of MAPK1                                                                                64762         9.44e-02   **1.61e-03**               **1.88e-02**                 −1.00               1.54             1.23                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***GAS2L3***         growth arrest-specific 2 like 3                                                                                    283431        5.77e-02   2.78e-01                   **1.30e-02**                 1.92                −1.14            −1.17   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GCLC***           glutamate-cysteine ligase, catalytic subunit                                                                       2729          3.29e-02   **2.08e-03**               7.58e-01                     1.56                1.53             1.32    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***GCLM***           glutamate--cysteine ligase, modifier subunit                                                                       2730          1.37e-02   **1.51e-03**               5.69e-01                     1.71                1.40             1.35    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GLCCI1***         glucocorticoid induced transcript 1                                                                                113263        2.69e-02   **1.03e-04**               8.16e-01                     1.37                1.38             1.28    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***GPR56***          G protein-coupled receptor 56                                                                                      9289          1.49e-02   **3.94e-03**               7.47e-02                     −1.85               −1.09            −1.27   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GPR89A***         G protein-coupled receptor 89A                                                                                     653519        5.78e-02   **3.12e-03**               3.52e-01                     1.67                1.32             1.22    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GRB7***           growth factor receptor-bound protein 7                                                                             2886          1.09e-02   **1.07e-03**               5.88e-02                     −1.74               −1.18            −1.18   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***GTF2B***          general transcription factor IIB                                                                                   2959          6.15e-04   **8.75e-05**               1.99e-01                     1.69                1.35             1.29    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***HCAR1***          hydroxycarboxylic acid receptor 1                                                                                  27198         9.99e-02   **3.02e-03**               7.95e-01                     −1.29               −1.45            −1.49                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***HILPDA***         hypoxia inducible lipid droplet-associated                                                                         29923         7.25e-05   **9.73e-04**               **3.21e-03**                 −1.20               −1.01            −2.09                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***HIST1H2AK***      histone cluster 1, H2ak                                                                                            8330          3.09e-03   **2.95e-03**               1.11e-01                     −1.05               −1.71            −1.85                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***HIST2H2BF***      histone cluster 2, H2bf                                                                                            440689        4.80e-03   **4.43e-05**               6.62e-01                     1.36                1.32             1.47    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***HIST2H4A***       histone cluster 2, H4a                                                                                             8370          0.00e+00   **4.91e-07**               **1.85e-02**                 1.87                1.46             1.32    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***HK2***            hexokinase 2                                                                                                       3099          1.25e-06   **4.59e-04**               **1.65e-03**                 1.06                −1.37            −2.25                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***HMMR***           hyaluronan-mediated motility receptor (RHAMM)                                                                      3161          1.23e-02   2.21e-01                   **8.49e-03**                 1.58                −1.43            −1.71   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*](#tbl1fnStar){ref-type="table-fn"}
  ***HMOX1***          heme oxygenase (decycling) 1                                                                                       3162          1.69e-02   **3.20e-04**               3.02e-01                     −1.51               −1.19            −1.41   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ID2***            inhibitor of DNA binding 2, dominant negative helix-loop-helix protein                                             3398          5.45e-03   **1.51e-04**               **1.15e-02**                 1.38                1.58             1.03    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***IDI1***           isopentenyl-diphosphate delta isomerase 1                                                                          3422          6.89e-02   **4.10e-03**               2.47e-01                     1.70                1.21             1.23    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***IGFL1***          IGF-like family member 1                                                                                           374918        0.00e+00   **1.06e-05**               8.05e-01                     −2.11               −2.05            −2.41   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***IL1B***           interleukin 1, beta                                                                                                3553          2.12e-03   **1.50e-03**               3.88e-01                     −1.29               −1.92            −1.69                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***IL32***           interleukin 32                                                                                                     9235          3.56e-03   **8.70e-05**               1.94e-01                     −1.23               −1.34            −1.59                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***IL7R***           interleukin 7 receptor                                                                                             3575          2.09e-04   **7.60e-04**               8.60e-02                     −1.11               −1.95            −1.69                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***IRF2BP2***        interferon regulatory factor 2 binding protein 2                                                                   359948        1.26e-02   7.17e-02                   **2.00e-04**                 −1.65               1.11             1.13    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ISCA1***          iron--sulfur cluster assembly 1 homolog (*S. cerevisiae*)                                                          81689         2.42e-02   **2.41e-03**               1.97e-01                     1.60                1.54             1.10    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***ISG20L2***        interferon stimulated exonuclease gene 20 kDa-like 2                                                               81875         8.45e-02   **4.01e-02**               **2.40e-03**                 −1.62               1.08             1.03    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***KCTD11***         potassium channel tetramerisation domain containing 11                                                             147040        4.26e-05   **1.92e-04**               3.55e-01                     −1.91               −1.36            −1.65   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***KDELC1***         KDEL (Lys-Asp-Glu-Leu) containing 1                                                                                79070         5.23e-02   **7.58e-05**               3.32e-01                     1.20                1.43             1.30                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***KHDRBS3***        KH domain containing, RNA binding, signal transduction associated 3                                                10656         1.79e-03   **2.61e-06**               **7.74e-04**                 1.05                1.57             1.32                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***KIAA0922***       KIAA0922                                                                                                           23240         1.60e-02   **1.12e-03**               3.47e-01                     1.25                1.68             1.35                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***KIAA1524***       KIAA1524                                                                                                           57650         2.09e-02   3.06e-01                   **1.10e-02**                 1.64                −1.68            −1.44   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***KIF14***          kinesin family member 14                                                                                           9928          1.42e-02   8.55e-01                   **1.29e-02**                 2.46                −1.70            −1.31   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***KIF23***          kinesin family member 23                                                                                           9493          7.31e-02   1.00e+00                   **1.64e-02**                 1.88                −1.46            −1.29   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***KLRAP1***         killer cell lectin-like receptor subfamily A pseudogene 1                                                          10748         9.99e-02   9.35e-01                   **2.08e-02**                 1.86                −1.58            −1.22   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***KRT16***          keratin 16                                                                                                         3868          8.89e-04   **7.06e-04**               5.60e-01                     −1.73               −1.76            −1.37   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***KRT17***          keratin 17                                                                                                         3872          1.35e-03   **6.95e-04**               2.03e-01                     −1.86               −1.24            −1.43   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***KRT34***          keratin 34                                                                                                         3885          6.82e-02   **5.18e-04**               8.08e-01                     −1.27               −1.37            −1.40                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***LAMB3***          laminin, beta 3                                                                                                    3914          9.31e-03   **7.05e-04**               8.37e-01                     −1.57               −1.44            −1.39   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***LIF***            leukemia inhibitory factor                                                                                         3976          1.04e-03   **1.87e-02**               **1.93e-03**                 −1.34               1.51             1.62    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***LMCD1***          LIM and cysteine-rich domains 1                                                                                    29995         7.13e-02   **2.87e-04**               8.53e-01                     −1.38               −1.33            −1.28   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***LOC100130713***   uncharacterized LOC100130713                                                                                       100130713     8.73e-03   **3.78e-02**               **1.06e-03**                 −1.33               1.51             1.34    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***LOC440896***      uncharacterized LOC440896                                                                                          440896        1.04e-02   **7.89e-04**               8.40e-01                     −1.55               −1.49            −1.37   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***LOX***            lysyl oxidase                                                                                                      4015          2.52e-02   **2.34e-04**               **3.94e-02**                 −1.15               −1.19            −1.60                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***LPIN1***          lipin 1                                                                                                            23175         1.40e-03   **2.40e-04**               **4.71e-02**                 1.72                1.37             1.12    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***MARCH8***         membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase                                             220972        7.20e-02   **2.41e-03**               2.60e-01                     1.12                1.54             1.42                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***MEF2D***          myocyte enhancer factor 2D                                                                                         4209          4.21e-03   9.11e-02                   **1.55e-03**                 −1.84               1.24             −1.00   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***MEGF9***          multiple EGF-like-domains 9                                                                                        1955          1.01e-04   **2.69e-04**               9.48e-01                     1.62                1.76             1.69    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***MERTK***          c-mer proto-oncogene tyrosine kinase                                                                               10461         6.83e-05   **2.96e-05**               6.07e-02                     1.28                1.79             1.32    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***MINPP1***         multiple inositol-polyphosphate phosphatase 1                                                                      9562          4.12e-02   **2.07e-03**               6.87e-01                     1.51                1.54             1.28    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***MIR29A***         microRNA 29a                                                                                                       407021        6.91e-05   **9.06e-04**               3.57e-01                     1.59                1.74             2.69                                                                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***MKI67***          antigen identified by monoclonal antibody Ki-67                                                                    4288          2.28e-02   6.57e-01                   **1.27e-02**                 2.18                −1.58            −1.13   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***MMP1***           matrix metallopeptidase 1 (interstitial collagenase)                                                               4312          1.40e-04   **1.11e-03**               **3.61e-02**                 −1.08               −1.44            −2.18                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***MMP10***          matrix metallopeptidase 10 (stromelysin 2)                                                                         4319          5.96e-08   **1.29e-04**               **1.54e-03**                 −1.02               −1.38            −2.37                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***MMP3***           matrix metallopeptidase 3 (stromelysin 1, progelatinase)                                                           4314          1.93e-05   **1.63e-03**               **2.51e-02**                 −1.01               −1.63            −2.57   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***MOB3C***          MOB kinase activator 3C                                                                                            148932        2.40e-02   **1.54e-02**               **7.70e-03**                 −1.78               1.01             −1.02   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***MYLIP***          myosin regulatory light chain interacting protein                                                                  29116         0.00e+00   **9.67e-07**               **8.89e-05**                 2.84                1.52             1.12    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***NAV3***           neuron navigator 3                                                                                                 89795         7.05e-02   6.46e-01                   **6.03e-03**                 1.55                −1.42            −1.24   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***NCAPG***          non-SMC condensin I complex, subunit G                                                                             64151         8.61e-02   7.39e-01                   **1.66e-02**                 1.89                −1.41            −1.18   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***NEK2***           NIMA-related kinase 2                                                                                              4751          5.47e-02   2.39e-01                   **7.63e-03**                 1.78                −1.23            −1.04   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***NINJ1***          ninjurin 1                                                                                                         4814          6.07e-02   **5.10e-03**               8.39e-02                     −1.70               −1.25            −1.06   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***NIPAL4***         NIPA-like domain containing 4                                                                                      348938        4.83e-03   **6.92e-04**               3.07e-01                     −1.74               −1.31            −1.32   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***NR4A2***          nuclear receptor subfamily 4, group A, member 2                                                                    4929          2.09e-03   5.30e-01                   **1.08e-03**                 −1.85               1.21             1.31    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***NUAK2***          NUAK family, SNF1-like kinase, 2                                                                                   81788         1.41e-02   **3.76e-04**               1.70e-01                     −1.60               −1.19            −1.30   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***NXF1***           nuclear RNA export factor 1                                                                                        10482         1.95e-02   **4.17e-04**               7.68e-02                     1.19                1.63             1.20                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***OLFM2***          olfactomedin 2                                                                                                     93145         9.51e-02   **4.42e-03**               7.98e-02                     −1.65               −1.13            −1.14   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***OSBPL11***        oxysterol binding protein-like 11                                                                                  114885        9.51e-02   **8.43e-03**               4.90e-01                     1.84                1.30             1.37    [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***OXTR***           oxytocin receptor                                                                                                  5021          1.11e-03   **9.51e-06**               **5.52e-03**                 −1.10               −1.62            −1.32                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***P4HA1***          prolyl 4-hydroxylase, alpha polypeptide I                                                                          5033          1.04e-04   4.09e-01                   **3.61e-04**                 1.58                −1.02            −1.89   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***PCF11***          PCF11, cleavage and polyadenylation factor subunit, homolog (*S. cerevisiae*)                                      51585         2.42e-02   **3.67e-02**               **3.25e-02**                 2.13                −1.01            1.06    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PDGFB***          platelet-derived growth factor beta polypeptide                                                                    5155          2.00e-04   **6.09e-04**               9.34e-02                     −2.09               −1.26            −1.36   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PDK1***           pyruvate dehydrogenase kinase, isozyme 1                                                                           5163          1.91e-06   **2.69e-02**               **4.56e-04**                 1.44                −1.19            −2.37   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***PDZK1IP1***       PDZK1 interacting protein 1                                                                                        10158         3.32e-02   **2.18e-03**               6.99e-02                     −1.60               −1.03            −1.39   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***PER1***           period circadian clock 1                                                                                           5187          1.43e-02   6.69e-02                   **3.66e-03**                 −1.84               1.08             1.08    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PFKFB4***         6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4                                                              5210          0.00e+00   **3.32e-04**               **6.63e-05**                 −1.06               1.04             −2.67                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***PHLDA3***         pleckstrin homology-like domain, family A, member 3                                                                23612         4.60e-02   **7.89e-04**               5.33e-01                     −1.52               −1.27            −1.31   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***PIK3R1***         phosphoinositide-3-kinase, regulatory subunit 1 (alpha)                                                            5295          2.59e-03   **1.84e-02**               **2.19e-02**                 2.40                1.14             −1.02   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PIK3R3***         phosphoinositide-3-kinase, regulatory subunit 3 (gamma)                                                            8503          1.86e-02   **4.86e-04**               5.59e-01                     1.28                1.54             1.37                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***PLAT***           plasminogen activator, tissue                                                                                      5327          3.74e-02   **1.90e-02**               1.06e-01                     −2.20               −1.18            −1.12   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PLCB4***          phospholipase C, beta 4                                                                                            5332          7.45e-06   **3.68e-02**               **2.37e-03**                 1.73                −2.07            −2.14   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***PLEKHG2***        pleckstrin homology domain containing, family G (with RhoGef domain) member 2                                      64857         3.71e-02   **3.43e-03**               7.01e-02                     −1.72               −1.23            −1.08   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PLEKHM1***        pleckstrin homology domain containing, family M (with RUN domain) member 1                                         9842          8.05e-02   9.03e-02                   **1.43e-02**                 −1.28               1.65             1.26                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***PLEKHM3***        pleckstrin homology domain containing, family M, member 3                                                          389072        3.51e-02   **4.36e-03**               9.12e-01                     1.57                1.78             1.56                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***PODXL***          podocalyxin-like                                                                                                   5420          1.55e-02   **8.88e-04**               **9.91e-03**                 −1.05               −1.16            −1.69                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***POLA1***          polymerase (DNA directed), alpha 1, catalytic subunit                                                              5422          9.69e-02   3.40e-01                   **2.19e-02**                 1.95                −1.35            −1.00   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PPP1R18***        protein phosphatase 1, regulatory subunit 18                                                                       170954        2.09e-02   **7.61e-03**               **1.02e-02**                 −1.77               −1.06            −1.02   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PPP1R3C***        protein phosphatase 1, regulatory subunit 3C                                                                       5507          1.19e-02   **9.34e-03**               7.03e-02                     1.04                −1.54            −1.94                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***PRDM1***          PR domain containing 1, with ZNF domain                                                                            639           0.00e+00   **1.29e-05**               **3.46e-06**                 −2.47               −1.04            −1.01   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***PRKCA***          protein kinase C, alpha                                                                                            5578          3.16e-03   **6.04e-04**               9.57e-01                     1.48                1.59             1.54    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***PRSS22***         protease, serine, 22                                                                                               64063         2.23e-02   **3.34e-04**               8.39e-01                     −1.41               −1.43            −1.31   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***PTCH1***          patched 1                                                                                                          5727          8.87e-02   **1.19e-02**               **6.15e-03**                 −1.02               1.65             1.04                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***PTP4A3***         protein tyrosine phosphatase type IVA, member 3                                                                    11156         1.22e-04   **2.90e-04**               3.74e-01                     −1.51               −1.95            −1.41   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***PXDC1***          PX domain containing 1                                                                                             221749        3.90e-02   3.71e-01                   **2.02e-03**                 −1.66               1.16             1.19    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***RAI14***          retinoic acid induced 14                                                                                           26064         9.76e-02   7.26e-01                   **1.68e-02**                 1.87                −1.31            −1.26   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***RASD2***          RASD family, member 2                                                                                              23551         6.21e-02   **7.34e-04**               **2.19e-02**                 −1.58               −1.08            −1.15   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***RASSF5***         Ras association (RalGDS/AF-6) domain family member 5                                                               83593         9.60e-02   **2.47e-04**               6.95e-01                     −1.29               −1.39            −1.25                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***RIPK4***          receptor-interacting serine--threonine kinase 4                                                                    54101         1.33e-03   **3.07e-04**               **1.37e-02**                 −1.79               −1.10            −1.23   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***RND1***           Rho family GTPase 1                                                                                                27289         9.23e-03   **1.56e-02**               5.23e-02                     −1.12               1.59             2.06                                                                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***RNF103***         ring finger protein 103                                                                                            7844          6.68e-02   **2.52e-03**               9.20e-01                     1.44                1.51             1.37    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***RRM2***           ribonucleotide reductase M2                                                                                        6241          5.93e-02   **3.12e-03**               **1.19e-02**                 1.59                1.22             −1.04   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***S100A3***         S100 calcium binding protein A3                                                                                    6274          0.00e+00   **7.47e-06**               5.36e-02                     −2.37               −1.37            −2.05   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SAMD4A***         sterile alpha motif domain containing 4A                                                                           23034         7.19e-04   **4.28e-06**               7.70e-02                     1.22                1.56             1.36    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SELE***           selectin E                                                                                                         6401          2.45e-03   **2.50e-03**               **1.08e-02**                 −1.01               1.24             1.89                                                                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SEMA4C***         sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C   54910         9.90e-02   **1.27e-03**               8.89e-02                     −1.53               −1.26            −1.08   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***SERPINA3***       serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3                                12            2.93e-03   **4.08e-03**               1.68e-01                     −2.38               −1.29            −1.37   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SERPINB9***       serpin peptidase inhibitor, clade B (ovalbumin), member 9                                                          5272          4.70e-02   **4.96e-03**               1.48e-01                     −1.07               −1.39            −1.72                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SERPINH1***       serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)                871           6.23e-02   **1.47e-03**               4.28e-01                     −1.27               −1.27            −1.58                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SERPINI1***       serpin peptidase inhibitor, clade I (neuroserpin), member 1                                                        5274          2.82e-02   **1.25e-03**               6.61e-01                     1.54                1.28             1.46    [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*](#tbl1fnStar){ref-type="table-fn"}
  ***SLC2A1***         solute carrier family 2 (facilitated glucose transporter), member 1                                                6513          2.93e-03   **1.28e-03**               6.12e-02                     −1.23               −1.19            −1.91                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SLC33A1***        solute carrier family 33 (acetyl-CoA transporter), member 1                                                        9197          6.24e-02   **6.09e-04**               3.29e-01                     1.42                1.42             1.16    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***SLC35D1***        solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1               23169         5.29e-02   **3.06e-03**               6.97e-01                     1.65                1.38             1.35    [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***SLC6A14***        solute carrier family 6 (amino acid transporter), member 14                                                        11254         8.97e-02   **5.67e-03**               8.88e-02                     1.01                −1.46            −1.50                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***SLC6A8***         solute carrier family 6 (neurotransmitter transporter, creatine), member 8                                         6535          2.16e-03   **1.14e-03**               **1.69e-02**                 −1.03               1.70             1.47                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SMIM14***         small integral membrane protein 14                                                                                 201895        7.25e-02   **3.85e-03**               4.08e-01                     1.19                1.64             1.41                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***SNHG12***         small nucleolar RNA host gene 12 (non-protein coding)                                                              85028         2.55e-04   **1.61e-05**               6.39e-02                     1.66                1.38             1.21    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***SNORA61***        small nucleolar RNA, H/ACA box 61                                                                                  677838        7.99e-04   **6.54e-05**               7.40e-02                     1.62                1.45             1.15    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***SNORD105***       small nucleolar RNA, C/D box 105                                                                                   692229        1.18e-02   **5.73e-03**               9.15e-02                     −1.82               −1.58            −1.00   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***SNORD13P2***      small nucleolar RNA, C/D box 13 pseudogene 2                                                                       6077          1.60e-02   8.33e-02                   **5.74e-03**                 −1.88               1.16             1.01    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD14E***       small nucleolar RNA, C/D box 14E                                                                                   85391         1.44e-02   **1.01e-02**               9.15e-02                     2.17                1.21             1.14    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD22***        small nucleolar RNA, C/D box 22                                                                                    9304          1.49e-06   **3.21e-04**               **3.16e-02**                 2.57                1.32             1.34    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD28***        small nucleolar RNA, C/D box 28                                                                                    9300          4.12e-02   **1.90e-03**               1.47e-01                     1.66                1.14             1.26    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD30***        small nucleolar RNA, C/D box 30                                                                                    9299          1.45e-02   **3.29e-03**               **4.36e-02**                 1.82                1.11             1.16    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD31***        small nucleolar RNA, C/D box 31                                                                                    9298          5.13e-06   **9.26e-05**               **3.20e-03**                 2.08                1.18             1.17    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SNORD32A***       small nucleolar RNA, C/D box 32A                                                                                   26819         6.96e-02   **1.74e-02**               **3.10e-02**                 −1.66               −1.32            1.11    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SPRY4***          sprouty homolog 4 (Drosophila)                                                                                     81848         8.04e-02   **2.15e-03**               1.03e-01                     −1.59               −1.09            −1.25   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***SRGN***           serglycin                                                                                                          5552          1.96e-02   **1.14e-04**               7.38e-02                     −1.15               −1.28            −1.55                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***STAT5A***         signal transducer and activator of transcription 5A                                                                6776          8.68e-02   **6.33e-04**               6.45e-01                     −1.22               −1.38            −1.40                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***STC1***           stanniocalcin 1                                                                                                    6781          8.00e-04   **1.62e-03**               **1.37e-02**                 −1.21               −1.06            −2.01                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***STC2***           stanniocalcin 2                                                                                                    8614          9.30e-04   **1.85e-03**               **5.42e-03**                 1.01                −1.19            −1.93                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***STK17B***         serine/threonine kinase 17b                                                                                        9262          1.23e-03   **1.93e-03**               1.18e-01                     2.15                1.36             1.23    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***STX4***           syntaxin 4                                                                                                         6810          2.28e-03   **1.23e-04**               9.23e-01                     −1.49               −1.40            −1.43   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***SYDE1***          synapse defective 1, Rho GTPase, homolog 1 (*C. elegans*)                                                          85360         9.00e-02   **9.80e-04**               4.81e-01                     −1.43               −1.19            −1.40   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  [\*](#tbl1fnStar){ref-type="table-fn"}
  ***TAGLN***          transgelin                                                                                                         6876          3.45e-03   **3.65e-04**               6.89e-01                     −1.43               −1.37            −1.61   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***TAS2R4***         taste receptor, type 2, member 4                                                                                   50832         9.62e-02   **1.10e-02**               1.86e-01                     1.83                1.15             1.22    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***TFRC***           transferrin receptor (p90, CD71)                                                                                   7037          7.32e-02   3.99e-01                   **2.32e-02**                 2.18                −1.21            −1.23   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***TGFB1I1***        transforming growth factor beta 1 induced transcript 1                                                             7041          8.92e-05   **2.58e-05**               9.24e-01                     −1.47               −1.48            −1.55   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***TGFB2***          transforming growth factor, beta 2                                                                                 7042          1.50e-05   **2.51e-03**               **3.22e-03**                 1.19                −2.14            −1.52                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***TICAM1***         toll-like receptor adaptor molecule 1                                                                              148022        4.13e-03   **8.38e-03**               **8.32e-04**                 −1.79               1.05             1.01    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***TLE1***           transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)                                                   7088          3.37e-03   **1.25e-02**               **3.72e-04**                 −1.23               1.70             1.14    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***TM4SF18***        transmembrane 4L six family member 18                                                                              116441        3.05e-02   6.72e-02                   **2.10e-03**                 1.31                −1.24            −1.55   [\*](#tbl1fnStar){ref-type="table-fn"}                                                        [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***TMEM2***          transmembrane protein 2                                                                                            23670         2.67e-02   **5.08e-03**               6.27e-01                     2.00                1.44             1.53    [\*](#tbl1fnStar){ref-type="table-fn"}                                                        
  ***TNFAIP6***        tumor necrosis factor, alpha-induced protein 6                                                                     7130          1.27e-02   **4.06e-03**               2.87e-01                     −1.16               −1.70            −1.84                                                  [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***TNFRSF11B***      tumor necrosis factor receptor superfamily, member 11b                                                             4982          6.74e-06   **4.09e-04**               2.27e-01                     −1.49               −2.62            −1.70                                                  [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***TNFSF18***        tumor necrosis factor (ligand) superfamily, member 18                                                              8995          0.00e+00   **3.06e-06**               3.10e-01                     −2.41               −4.24            −3.41   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***TOP2A***          topoisomerase (DNA) II alpha 170 kDa                                                                               7153          4.62e-02   8.29e-01                   **1.18e-02**                 1.90                −1.42            −1.24   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***TRAF1***          TNF receptor-associated factor 1                                                                                   7185          2.49e-04   **8.97e-05**               2.32e-01                     −1.69               −1.50            −1.26   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***TRIP6***          thyroid hormone receptor interactor 6                                                                              7205          8.37e-02   **9.63e-04**               6.24e-01                     −1.48               −1.30            −1.26   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***TSGA10***         testis specific, 10                                                                                                80705         6.19e-02   **6.67e-03**               **1.65e-02**                 1.68                1.07             1.04    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***TTLL3***          tubulin tyrosine ligase-like family, member 3                                                                      26140         3.38e-03   **1.07e-03**               **1.29e-02**                 −1.04               1.65             1.45                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***UBALD1***         UBA-like domain containing 1                                                                                       124402        1.29e-02   9.81e-02                   **5.00e-03**                 −1.88               1.23             −1.03   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ULBP3***          UL16 binding protein 3                                                                                             79465         5.51e-02   **3.20e-04**               1.21e-01                     1.30                1.50             1.12    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***ULK1***           unc-51-like kinase 1 (*C. elegans)*                                                                                8408          8.48e-02   4.11e-01                   **2.45e-03**                 −1.44               1.33             1.27    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***USP38***          ubiquitin specific peptidase 38                                                                                    84640         8.54e-03   **1.46e-04**               4.15e-01                     1.53                1.34             1.27    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}
  ***VAMP1***          vesicle-associated membrane protein 1 (synaptobrevin 1)                                                            6843          1.08e-03   **3.77e-05**               4.65e-01                     1.49                1.48             1.28    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   [\*](#tbl1fnStar){ref-type="table-fn"}
  ***VLDLR***          very low density lipoprotein receptor                                                                              7436          4.04e-02   **4.49e-04**               **2.18e-03**                 −1.05               −1.08            −1.61                                                                                                 [\*\*](#tbl1fnStarStar){ref-type="table-fn"}
  ***ZC3H7B***         zinc finger CCCH-type containing 7B                                                                                23264         6.99e-02   **4.01e-04**               8.97e-01                     −1.39               −1.30            −1.32   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZC3HAV1***        zinc finger CCCH-type, antiviral 1                                                                                 56829         4.54e-02   **3.89e-03**               2.25e-01                     1.74                1.29             1.17    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZCCHC14***        zinc finger, CCHC domain containing 14                                                                             23174         3.05e-02   **1.36e-03**               9.05e-02                     1.11                1.66             1.27                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***ZNF253***         zinc finger protein 253                                                                                            56242         5.52e-02   **2.43e-02**               1.07e-01                     2.18                1.16             1.11    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZNF426***         zinc finger protein 426                                                                                            79088         6.98e-02   **3.42e-03**               7.62e-01                     1.55                1.51             1.30    [\*](#tbl1fnStar){ref-type="table-fn"}         [\*](#tbl1fnStar){ref-type="table-fn"}         
  ***ZNF48***          zinc finger protein 48                                                                                             197407        5.05e-02   **5.04e-03**               **1.14e-02**                 −1.67               −1.07            −1.03   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZNF487P***        zinc finger protein 487, pseudogene                                                                                642819        5.33e-05   **1.01e-03**               5.62e-02                     1.47                2.43             1.18                                                   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}   
  ***ZNF724P***        zinc finger protein 724, pseudogene                                                                                440519        3.69e-02   1.45e-01                   **1.73e-02**                 2.07                −1.05            −1.15   [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZNF737***         zinc finger protein 737                                                                                            100129842     2.08e-02   **6.03e-03**               3.48e-01                     2.11                1.29             1.46    [\*\*](#tbl1fnStarStar){ref-type="table-fn"}                                                  
  ***ZSWIM6***         zinc finger, SWIM-type containing 6                                                                                57688         4.63e-02   **5.34e-03**               4.44e-01                     1.55                1.78             1.22                                                   [\*](#tbl1fnStar){ref-type="table-fn"}         

*P*-values in bold if significant at two-factor ANOVA (\<0.05).

FDR: false discovery rate, according to BETR analysis. *P*~*treatment*~: *P*-value for treatment effect; and *P*~*interaction*~: *P*-value for interaction effect, at two-factor ANOVA. FC: fold-change in Aminaphtone-treated *vs.* untreated IL-1β-stimulated endothelial cells. AMNA: Aminaphtone. Pairwise: pairwise significant at two-tailed *t*-test.

*P*\<0.05.

*P*\<0.01 at two-tailed *t*-test.

###### 

Gene sets significantly modulated by Aminaphtone in treated *vs.* untreated IL-1β-stimulated endothelial cells.

  **GO Category**[a](#tbl2fna){ref-type="table-fn"}   **GO Ontology**   **GO term**                                                                 **\#genes**   **LS**         **KS**         **Gene list**
  --------------------------------------------------- ----------------- --------------------------------------------------------------------------- ------------- -------------- -------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  0005975                                             BP                carbohydrate metabolic process                                              11            0.0805         **0.0028**     *DDIT4*, *ENO2*, *FUT11*, *GCLC*, *HK2*, *HMMR*, *PDGFB*, *PDK1*, *PFKFB4*, *PPP1R3C*, *SLC2A1*
  0007166                                             BP                cell surface receptor signaling pathway                                     46            0.0260         **0.0020**     *AAK1*, *BCL2L11*, *BMP6*, *CBLB*, *CITED2*, *CX3CL1*, *DDIT4*, *DDR1*, *DKK1*, *EBI3*, *ECT2*, *EDN1*, *EFNA1*, *EFNB2*, *EIF4B*, *EIF4EBP2*, *FOS*, *FST*, *GAREM*, *GPR56*, *GRB7*, *IL1B*, *IL7R*, *KCTD11*, *LIF*, *MERTK*, *OXTR*, *PDGFB*, *PIK3R1*, *PIK3R3*, *PLAT*, *PLEKHG2*, *PRDM1*, *PRKCA*, *PTCH1*, *SEMA4C*, *STAT5A*, *STC1*, *STC2*, *TGFB1I1*, *TGFB2*, *TICAM1*, *TLE1*, *TNFSF18*, *ULK1*, *VLDLR*
  0022411                                             BP                cellular component disassembly                                              7             **0.0042**     0.8859         *BNIP3*, *DDIT4*, *DDR1*, *MMP1*, *MMP10*, *MMP3*, *TOP2A*
  0048732                                             BP                gland development                                                           11            **0.0031**     **0.0022**     *BCL2L11*, *CITED2*, *DDR1*, *ELF3*, *HK2*, *ID2*, *OXTR*, *PDGFB*, *PTCH1*, *STAT5A*, *TGFB2*
  0042592                                             BP                homeostatic process                                                         26            **0.0015**     0.2886         *BCL2L11*, *BNIP3*, *CITED2*, *CTSK*, *EDN1*, *EGR2*, *GCLC*, *GCLM*, *GPR89A*, *HK2*, *HMOX1*, *ID2*, *IL1B*, *IL7R*, *MYLIP*, *OXTR*, *POLA1*, *PRKCA*, *PTCH1*, *SERPINA3*, *STAT5A*, *STC1*, *STC2*, *TFRC*, *TGFB2*, *TNFRSF11B*
  0002376                                             BP                immune system process                                                       47            **0.0015**     0.0284         *ANXA3*, *BCL2L11*, *BCL3*, *BMP6*, *BNIP3*, *CBLB*, *CCL22*, *CD70*, *CD83*, *CITED2*, *CLEC4E*, *CSF2*, *CTSK*, *CX3CL1*, *CXCL3*, *CXCL6*, *DDIT4*, *EBI3*, *EDN1*, *FOS*, *FST*, *GRB7*, *HMOX1*, *ID2*, *IL1B*, *IL32*, *IL7R*, *KIF23*, *LIF*, *MARCH8*, *MERTK*, *MMP1*, *PDGFB*, *PIK3R1*, *PIK3R3*, *PODXL*, *PRDM1*, *PRKCA*, *SELE*, *SERPINB9*, *STAT5A*, *TFRC*, *TGFB2*, *TICAM1*, *TNFSF18*, *ULBP3*, *ZC3HAV1*
  0006954                                             BP                inflammatory response                                                       15            0.0131         **0.0047**     *BMP6*, *CCL22*, *CX3CL1*, *CXCL3*, *CXCL6*, *ELF3*, *FOS*, *HMOX1*, *IL1B*, *PRKCA*, *SELE*, *SERPINA3*, *STAT5A*, *TICAM1*, *TNFAIP6*
  0043066                                             BP                negative regulation of apoptotic process                                    20            **0.0028**     0.0677         *AGAP2*, *BCL3*, *BNIP3*, *CITED2*, *CSF2*, *CTH*, *CX3CL1*, *EDN1*, *GCLC*, *GCLM*, *HMOX1*, *IL1B*, *NR4A2*, *NUAK2*, *PIK3R1*, *PRKCA*, *SERPINB9*, *STAT5A*, *TLE1*, *TNFSF18*
  0007389                                             BP                pattern specification process                                               6             0.0137         **0.0006**     *CITED2*, *DKK1*, *EDN1*, *EGR2*, *FST*, *PTCH1*
  0010646                                             BP                regulation of cell communication                                            49            0.1744         **0.0034**     *AAK1*, *ACAP1*, *AGAP2*, *ANKRD1*, *ARHGEF26*, *BCL2L11*, *BCL3*, *BMP6*, *BNIP3*, *CBLB*, *CITED2*, *CSF2*, *CTH*, *DDIT4*, *DKK1*, *DUSP8*, *ECT2*, *EDN1*, *EFNA1*, *EGR2*, *FST*, *GAREM*, *GPR89A*, *HMOX1*, *IL1B*, *KCTD11*, *LIF*, *LMCD1*, *OXTR*, *PDGFB*, *PHLDA3*, *PLAT*, *PLEKHG2*, *PRDM1*, *PRKCA*, *PTCH1*, *RASD2*, *SEMA4C*, *SLC2A1*, *SPRY4*, *SYDE1*, *TGFB1I1*, *TGFB2*, *TICAM1*, *TLE1*, *TRAF1*, *TRIP6*, *ULK1*, *ZC3HAV1*
  0042127                                             BP                regulation of cell proliferation                                            23            **0.0019**     0.0322         *BMP6*, *BRCA1*, *CBLB*, *CSF2*, *DDR1*, *EBI3*, *EDN1*, *GAREM*, *HILPDA*, *HMOX1*, *ID2*, *IL1B*, *KCTD11*, *LIF*, *PDGFB*, *PRDM1*, *PRKCA*, *PTCH1*, *STAT5A*, *TGFB1I1*, *TGFB2*, *TICAM1*, *TNFSF18*
  0045619                                             BP                regulation of lymphocyte differentiation                                    5             **0.0009**     **0.0034**     *CD83*, *ID2*, *IL7R*, *PRDM1*, *STAT5A*
  0051246                                             BP                regulation of protein metabolic process                                     38            0.0567         **0.0032**     *AGAP2*, *BCL3*, *BMP6*, *BRCA1*, *BUB1B*, *CBLB*, *CSF2*, *DDIT4*, *DKK1*, *DUSP8*, *EBI3*, *ECT2*, *EDN1*, *EFNA1*, *EIF4B*, *EIF4EBP2*, *GCLC*, *GRB7*, *HMOX1*, *IL1B*, *KRT17*, *LIF*, *LPIN1*, *MYLIP*, *PDGFB*, *PLAT*, *PRKCA*, *RASD2*, *SAMD4A*, *SERPINA3*, *SERPINB9*, *SERPINH1*, *SERPINI1*, *SPRY4*, *STAT5A*, *TGFB2*, *TICAM1*, *VLDLR*
  0051090                                             BP                regulation of sequence-specific DNA binding transcription factor activity   10            **0.0020**     0.0058         *ANXA3*, *CTH*, *FOS*, *HMOX1*, *ID2*, *IL1B*, *PTCH1*, *TICAM1*, *TNFSF18*, *TRAF1*
  0006357                                             BP                regulation of transcription from RNA polymerase II promoter                 30            **0.0035**     0.6000         *ANKRD1*, *BCL3*, *BMP6*, *BRCA1*, *CITED2*, *DKK1*, *EDN1*, *EFNA1*, *EGR2*, *ELF3*, *ERF*, *FOS*, *FST*, *HMOX1*, *ID2*, *IL1B*, *LIF*, *LMCD1*, *LPIN1*, *MEF2D*, *NR4A2*, *PER1*, *PIK3R1*, *POLA1*, *PRDM1*, *PTCH1*, *RRM2*, *STAT5A*, *TOP2A*, *VLDLR*
  0036293                                             BP                response to decreased oxygen levels                                         14            **0.0024**     **0.0002**     *ANKRD1*, *BNIP3*, *CITED2*, *DDIT4*, *EDN1*, *HMOX1*, *NR4A2*, *OXTR*, *PDGFB*, *PDK1*, *PLAT*, *STC1*, *STC2*, *TGFB2*
  0009605                                             BP                response to external stimulus                                               32            **0.0001**     0.0071         *AGAP2*, *ANKRD1*, *BNIP3*, *CCL22*, *CITED2*, *CX3CL1*, *CXCL3*, *CXCL6*, *CYP24A1*, *EDN1*, *EFNB2*, *EGR2*, *ELOVL4*, *FOS*, *HMOX1*, *ID2*, *IL1B*, *NR4A2*, *NUAK2*, *PDGFB*, *PER1*, *PLAT*, *PRKCA*, *RND1*, *SELE*, *SLC2A1*, *STAT5A*, *STC1*, *STC2*, *TGFB2*, *TNFRSF11B*, *ULK1*
  0010033                                             BP                response to organic substance                                               48            **\<0.0001**   0.0168         *ANKRD1*, *BMP6*, *BRCA1*, *CD83*, *CITED2*, *CSF2*, *CTH*, *CX3CL1*, *CYP24A1*, *DKK1*, *DNAJB1*, *EBI3*, *EDN1*, *EGR2*, *EIF4B*, *EIF4EBP2*, *FOS*, *GAREM*, *GCLC*, *HCAR1*, *HMOX1*, *IDI1*, *IL1B*, *IL7R*, *LOX*, *LPIN1*, *MMP3*, *NR4A2*, *OXTR*, *PDGFB*, *PIK3R1*, *PIK3R3*, *PLAT*, *PRDM1*, *PRKCA*, *PTCH1*, *SELE*, *SERPINB9*, *SERPINH1*, *STAT5A*, *STC1*, *STC2*, *TGFB1I1*, *TGFB2*, *TICAM1*, *TNFRSF11B*, *TNFSF18*, *ZC3HAV1*
  0048511                                             BP                rhythmic process                                                            6             **0.0033**     0.0194         *EGR2*, *ID2*, *OXTR*, *PER1*, *STAT5A*, *TGFB2*
  0046903                                             BP                secretion                                                                   20            0.0238         **0.0008**     *ANKRD1*, *ANXA3*, *BMP6*, *CLEC4E*, *DDR1*, *EDN1*, *FST*, *HK2*, *HMOX1*, *IL1B*, *LIF*, *MERTK*, *OXTR*, *PDGFB*, *PRKCA*, *SLC2A1*, *SRGN*, *STAT5A*, *TGFB2*, *VAMP1*
  0005125                                             MF                cytokine activity                                                           15            0.0061         **0.0047**     *BMP6*, *CCL22*, *CD70*, *CSF2*, *CX3CL1*, *CXCL3*, *CXCL6*, *EBI3*, *EDN1*, *IL1B*, *IL32*, *LIF*, *TGFB2*, *TNFRSF11B*, *TNFSF18*
  0004175                                             MF                endopeptidase activity                                                      6             **0.0004**     0.1037         *CTSK*, *MMP1*, *MMP10*, *MMP3*, *PLAT*, *PRSS22*
  0001071                                             MF                nucleic acid binding transcription factor activity                          11            **0.0006**     0.0382         *BCL3*, *CEBPD*, *CITED2*, *EGR2*, *ELF3*, *ERF*, *FOS*, *MEF2D*, *NR4A2*, *PRDM1*, *STAT5A*
  0000988                                             MF                protein binding transcription factor activity                               11            0.0990         **0.0032**     *ANKRD1*, *BRCA1*, *CITED2*, *ELF3*, *ERF*, *LIF*, *LMCD1*, *LPIN1*, *PER1*, *TGFB1I1*, *TLE1*
  0019904                                             MF                protein domain specific binding                                             5             **0.0031**     0.0167         *ACAP1*, *CITED2*, *EGR2*, *IL1B*, *KHDRBS3*
  0001067                                             MF                regulatory region nucleic acid binding                                      6             **0.0040**     0.0378         *BRCA1*, *EGR2*, *FOS*, *MEF2D*, *PER1*, *STAT5A*
  0031012                                             CC                extracellular matrix                                                        9             **0.0034**     **0.0040**     *LAMB3*, *LMCD1*, *LOX*, *MMP1*, *MMP10*, *MMP3*, *TGFB1I1*, *TGFB2*, *TNFRSF11B*
  0005615                                             CC                extracellular space                                                         31            **0.0003**     **\<0.0001**   *BMP6*, *CCL22*, *CD70*, *CSF2*, *CTSK*, *CX3CL1*, *CXCL3*, *CXCL6*, *DKK1*, *EBI3*, *EDN1*, *HILPDA*, *HMOX1*, *IGFL1*, *IL1B*, *IL32*, *LIF*, *LMCD1*, *LOX*, *MERTK*, *MMP10*, *MMP3*, *PLAT*, *SELE*, *SERPINB9*, *SRGN*, *STC1*, *TGFB2*, *TNFRSF11B*, *TNFSF18*, *VLDLR*

                                                                             
  ---------- ---------------------------------------- ---- -------- -------- ----------------------------------------------------------------------------------------------------------------------
  hsa04060   Cytokine-cytokine receptor interaction   13   0.0287   0.0095   *CCL22*, *CD70*, *CSF2*, *CX3CL1*, *CXCL3*, *CXCL6*, *IL1B*, *IL7R*, *LIF*, *PDGFB*, *TGFB2*, *TNFRSF11B*, *TNFSF18*

                                                                               
  -------------------------------------------- ---- ------------- ------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HINATA_NFKB_TARGETS_KERATINOCYTE_UP          13   **0.0004**    0.0095       *CD83*, *CSF2*, *CXCL3*, *CXCL6*, *EFNA1*, *IL1B*, *IL32*, *IL7R*, *MMP1*, *PLAT*, *STAT5A*, *TNFAIP6*, *TRAF1*
  HINATA_NFKB_TARGETS_FIBROBLAST_UP            6    **0.0027**    0.1123       *CD83*, *CXCL3*, *CXCL6*, *IL1B*, *MMP1*, *SELE*
  SCHOEN_NFKB_SIGNALING                        5    0.0192        **0.0036**   *CSF2*, *EDN1*, *IL1B*, *NUAK2*, *SERPINA3*
  ELVIDGE_HYPOXIA_UP                           19   **0.0017**    **0.0010**   *AK4*, *BNIP3*, *CITED2*, *DDIT4*, *DDR1*, *ELF3*, *ENO2*, *FOS*, *HK2*, *LOX*, *P4HA1*, *PDGFB*, *PDK1*, *PRKCA*, *SAMD4A*, *SLC2A1*, *STC1*, *STC2*, *VLDLR*
  ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN           14   **0.0036**    **0.0001**   *AK4*, *BNIP3*, *CITED2*, *ENO2*, *FOS*, *HK2*, *LOX*, *P4HA1*, *PDGFB*, *PDK1*, *SAMD4A*, *SLC2A1*, *STC1*, *VLDLR*
  ELVIDGE_HYPOXIA_BY_DMOG_UP                   17   **0.0038**    **0.0023**   *AK4*, *BNIP3*, *CITED2*, *DDIT4*, *ELF3*, *ENO2*, *FOS*, *HK2*, *LOX*, *P4HA1*, *PDK1*, *PRKCA*, *SAMD4A*, *SLC2A1*, *STC1*, *STC2*, *VLDLR*
  ELVIDGE_HIF1A_TARGETS_DN                     13   0.0114        **0.0002**   *AK4*, *BNIP3*, *CITED2*, *ENO2*, *FOS*, *HK2*, *LOX*, *P4HA1*, *PDGFB*, *PDK1*, *SLC2A1*, *STC1*, *VLDLR*
  WINTER_HYPOXIA_METAGENE                      18   **0.0022**    0.0376       *BNIP3*, *CITED2*, *DDIT4*, *EDN1*, *EFNA1*, *ELF3*, *FOS*, *HK2*, *HMOX1*, *ID2*, *LOX*, *P4HA1*, *PDGFB*, *PFKFB4*, *SLC2A1*, *SLC6A8*, *STC2*, *TFRC*
  PID_HIF1_TFPATHWAY                           9    **0.0022**    0.2078       *BNIP3*, *CITED2*, *EDN1*, *FOS*, *HK2*, *HMOX1*, *ID2*, *SLC2A1*, *TFRC*
  MENSE_HYPOXIA_UP                             10   **0.0028**    **0.0004**   *BNIP3*, *CEBPD*, *ENO2*, *HK2*, *LOX*, *P4HA1*, *PDK1*, *PFKFB4*, *PPP1R3C*, *STC2*
  LEONARD_HYPOXIA                              11   0.0061        **0.0007**   *AK4*, *BNIP3*, *DDIT4*, *EFNA1*, *HK2*, *P4HA1*, *PDGFB*, *PFKFB4*, *PPP1R3C*, *SLC2A1*, *STC2*
  JIANG_HYPOXIA_NORMAL                         15   0.0134        **0.0009**   *AK4*, *BNIP3*, *CITED2*, *CNNM4*, *EIF4B*, *ENO2*, *HMOX1*, *KHDRBS3*, *LOX*, *P4HA1*, *PFKFB4*, *PPP1R3C*, *RIPK4*, *SLC2A1*, *STC2*
  KRIEG_HYPOXIA_VIA_KDM3A                      5    0.0182        **0.0026**   *C15orf48*, *CLEC4E*, *EDN1*, *HMOX1*, *LAMB3*
  FARDIN_HYPOXIA_11                            6    0.0200        **0.0029**   *AK4*, *BNIP3*, *DDIT4*, *FUT11*, *PDK1*, *PFKFB4*
  NAGASHIMA_EGF_SIGNALING_UP                   8    **0.0008**    **0.0007**   *AREG*, *DNAJB1*, *EDN1*, *EGR2*, *FOS*, *LIF*, *NR4A2*, *TNFRSF11B*
  ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP   22   **0.0021**    0.0070       *BCL3*, *C15orf48*, *CD83*, *CXCL3*, *DDIT4*, *EDN1*, *EFNA1*, *GCLC*, *IGFL1*, *IL1B*, *IL32*, *IL7R*, *LAMB3*, *LIF*, *MMP10*, *NAV3*, *NINJ1*, *SAMD4A*, *SEMA4C*, *SERPINB9*, *TNFAIP6*, *TRAF1*
  BASSO_CD40_SIGNALING_UP                      8    **0.00498**   0.0093       *CCL22*, *CD83*, *DDIT4*, *IL1B*, *PTP4A3*, *SRGN*, *STAT5A*, *TRAF1*
  WIERENGA_STAT5A_TARGETS_GROUP2               5    0.0163        **0.0036**   *CCL22*, *CD83*, *CSF2*, *IL7R*, *TRAF1*

GO ontology: BP=biological process, MF=molecular function, and CC=cellular component.

GO (Gene Ontology) categories,

KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways, and

MsigDB (Broad Institute Molecular Signature Database) curated gene sets found to be significant at the 0.005 significance level of either the LS or KS permutation tests. For each Gene Set, the table lists the unique identifier, the number of genes differentially modulated, the Fisher (LS) and Kolmogorov--Smirnov (KS) permutation *P*-values (*P*-values \<0.005 are in bold), and the list of modulated genes.
